Results 131 to 140 of about 15,848 (207)

Mitochondrial dysfunction activates ADAMTS-5 expression via mt-dsRNA-PKR-Spi-1 axis in osteoarthritic chondrocytes. [PDF]

iScience
Mu Y, Yan S, Wang Y, Liang B, Tang R, Yang H, Ma L, Zhang Y, Li D.   +8 more
europepmc   +1 more source

Current Advances in the Physiological Roles and Disease-Associated Mechanisms of ADAMTS16. [PDF]

Int J Mol Sci
Wang L, Zhang J, Zhang Y.
europepmc   +1 more source

Causes and outcomes of pediatric thrombotic microangiopathy. [PDF]

Res Pract Thromb Haemost
Scully M.
europepmc   +1 more source

Inflammaging and osteoarthritis - therapeutic opportunities. [PDF]

Front Immunol
Chan M, Low P, Ong SC, Choy SM, Lee WX, Goh KY, Ng KM, Chua K, Lee JY, Guo AK, Jia J, Tan EK, Tang HW, Chua K.   +13 more
europepmc   +1 more source

ADAMTS-7 Increase Contributes to Worsened Neurological Outcome in Mice on High Fat Diet. [PDF]

CNS Neurosci Ther
Xu Y, Li J, Zuo Z.
europepmc   +1 more source

ADAMTS-13 R1206K variant exhibits an open conformation and an enhanced proteolytic activity toward von Willebrand factor. [PDF]

J Thromb Haemost
Liu S, Dong X, Bonnez Q, Chai Z, Meng C, Gil M, Vanhoorelbeke K, Halkidis K, Zheng XL.   +8 more
europepmc   +1 more source

Cartilage destruction in joint disease: studies with ADAMTS-4 and ADAMTS-5 deficient mice

In healthy joints the proteoglycan, aggrecan, gives cartilage compressive resilience to permit weight bearing, but in disease aggrecan is degraded by ADAMTS enzymes.

core  

Solving another piece of the thrombotic thrombocytopenic purpura puzzle? [PDF]

Res Pract Thromb Haemost
Evangelidis P, Gavriilaki E.
europepmc   +1 more source

Daratumumab in relapse-refractory immune-mediated thrombotic thrombocytopenic purpura: additional evidence for its efficacy. [PDF]

Res Pract Thromb Haemost
Coppo P.
europepmc   +1 more source

<i>ADAMTS</i> and <i>ADAMTSL</i> Mutations in Connective Tissue Disorders. [PDF]

Physiology (Bethesda)
Alcocer AD, Rush EH, Mead TJ.
europepmc   +1 more source